new version available

Newsletter Sign Up

Please enter your email to receive FREE venture capital and private equity special offers, news, and information!

Your Name: 

Your Email:  

bookmark us

June 22, 2009

Accera Manages Alzheimer’s Disease With Axona

Filed under: Start-up Companies Reviews — admin @ 6:01 am

Since 2001, when Accera was founded, the company has been developing solutions for neurological degenerative disorders, especially Alzheimer’s Disease. After years of research, in March 3, 2009, Accera released its first product to market, Axona. Axona is not another drug, it is a medical dietary supplement for those suffering from mild to moderate Alzheimer’s disease.

How does Axona work? Simple. To understand how Axona works, you must first understand Alzheimer’s disease. According to Accera’s company website, Alzheimer’s disease is caused when the patient’s body is not able to metabolize glucose in the brain. Glucose, the scientific term for sugar, is the main fuel for the brain. Glucose is found in a wide variety of natural products from fruits and vegetables to meat and fish. Studies show that the brains of Alzheimer’s patients are not metabolizing the necessary amount of glucose to prevent the symptoms of Alzheimer’s disease. Until the advent of Axona, Alzheimer’s disease has largely remained untreated, leaving Alzhaimer’s patients to a bleak future with independent living not being an option anymore.

Some of the common symptoms of Alzheimer’s disease is that the afflicted person is unable to remember certain things and not being able to function properly in everyday life. In the more severe cases of Alzheimer’s disease, the afflicted cannot live by himself and needs round the clock care.

The way Axona works is that it is a special dietary medical food that provides the brain with the nutrients it needs to deter the further degradation that is synonymous with Alzheimer’s disease.

Though the Axona dietary treatment is already on the market and is having amazing results with patients suffering from mild to moderate Alzheimer’s disease, Accera is also working on therapies for other neurological disorders as well.

Along with Axona, Accera also has a therapy, that is currently undergoing clinical trials, to cure age-associated memory impairment. Furthermore, the company is researching different therapies for treating both Huntington’s and Parkinson’s diseases.

The founder of Accera is Dr. Steve A. Orndorff, who also continues to serves the company as its president and CEO. Dr. Orndorff is a seasoned entrepreneur with over 25 years of experience with biotechnology. Dr. Orndorff also worked at Univera Pharmaceuticals, Inc., where he also served as the company’s president and CEO. Univera Pharmaceuticals is a pharmaceutical company that develops solutions for inflammation and immune disorders. Dr. Orndorff also worked on other projects as well, such as research that led to the development of NutraSweet, Inc.

Accera is based in Broomfield, Colorado and employs 10 people.

Accera’s investors include Inventages Venture Capital and POSCO BioVentures, who both participated in the company’s seed and series A funding rounds.

Inventages Venture Partners was founded in 2000 and is a vc firm that is dedicated to the life sciences and biotech industries. The vc firm will aso fund companies that have a treatment which is effective and serves an unmet need. Inventages is a global vc firm is global with offices in Geneva, Switzerland; Nassau, Bahamas; and Aukland, New Zealand. Other companies in Inventages’ portfolio include AM Pharma, Atonomis, Biolactic, Boowl, Cavis, and others.

POSCO BioVentures is a vc firm that is solely dedicated to the biotech industry. POSCO is the brainchild of Dr. Leo Kim, PhD and the vc firm will invest in companies that have a promising effect in the health department. Some other companies in POSCO’s portfolio include Acorda, Anadys, Bioarray Solutions, and others.

Accera does not have any known competitors

For more information about Accera, click here.


Facebook comments:

Share This Post:  

Try out our Venture Capital Firms
and Angel Investors
database for FREE!

Enter your name and valid e-mail address to download our FREE
investor database trial version, then click the "Get It Now!" button

Your Name:    

Your Email:     

By continuing to use the site, you agree to the use of cookies. more information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.



Enter your name and valid Primary Email Address below now to download our FREE trial version, then click the "Get It Now!" button to start the downloading.

Your Name: 

Your Email: 

NOTICE: This is a spam-free site. Your email address will never be sold or traded and you may unsubscribe at anytime.

Tip: VCgate gives you access to 4,500+ venture capital and private equity investors worldwide at the touch of a button.